Strategies for Treatment Optimization and Adverse Event Reduction in Myelofibrosis
Dr Mahmoudjafari shares clinical strategies for optimizing patient outcomes and reducing the rate of adverse events and treatment discontinuations.
Video content above is prompted by the following question:
- At what point is it recommended for a patient's treatment regimen to change?
- What are some considerations for continuing or altering treatment regimens in myelofibrosis?
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
